[静脉注射非诺多泮对重度动脉高血压患者血压及肾功能的影响] - Suppr | 超能文献

[Effects of intravenous administration of fenoldopam on blood pressure and renal function in severe arterial hypertension].

作者信息

Miranda B, Ruilope L M, García Robles R, Alcázar J M, Sancho J, Tover J, Martínez A, Astorga M, Rodicio J L

出版信息

Med Clin (Barc). 1988 Oct 15;91(12):445-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Effects of intravenous administration of fenoldopam on blood pressure and renal function in severe arterial hypertension].[静脉注射非诺多泮对重度动脉高血压患者血压及肾功能的影响]

Med Clin (Barc). 1988 Oct 15;91(12):445-8.

2

Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.甲磺酸非诺多泮与硝普钠静脉给药对重度高血压患者肾脏的比较性影响。

Arch Intern Med. 1989 Apr;149(4):870-4.

3

Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam.重度高血压的选择性多巴胺-1激动剂治疗：静脉注射非诺多泮的效果

J Am Coll Cardiol. 1988 May;11(5):1118-23. doi: 10.1016/s0735-1097(98)90073-0.

4

Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.静脉注射甲磺酸非诺多泮与硝普钠治疗重度系统性高血压时急性血压降低效果的比较。

Am J Cardiol. 1989 Apr 15;63(13):993-6. doi: 10.1016/0002-9149(89)90157-4.

5

Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.

Circulation. 1987 Dec;76(6):1312-8. doi: 10.1161/01.cir.76.6.1312.

6

Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.非诺多泮静脉注射与靶向肾脏给药对接受心导管插入术患者肾功能和血压的不同影响。

Am J Cardiol. 2006 Apr 1;97(7):1076-81. doi: 10.1016/j.amjcard.2005.10.053. Epub 2006 Feb 28.

7

Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.非诺多泮急性外周多巴胺1受体激动作用的心血管和肾脏表现

Hypertension. 1987 Jul;10(1):43-54. doi: 10.1161/01.hyp.10.1.43.

8

Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator.甲磺酸非诺多泮（一种多巴胺能血管扩张剂）诱导大鼠产生的动脉病变的超微结构

Br J Exp Pathol. 1989 Apr;70(2):153-65.

9

Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.静脉输注多巴胺能血管扩张剂甲磺酸非诺多泮可诱导大鼠发生动脉中层坏死和出血。

Am J Pathol. 1985 Apr;119(1):83-91.

10

Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.多巴胺1受体激动剂静脉注射非诺多泮在高血压患者中的药代动力学和药效学特性。

Br J Clin Pharmacol. 1988 Jan;25(1):17-21. doi: 10.1111/j.1365-2125.1988.tb03276.x.

引用本文的文献

1

Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.非诺多泮：其药效学和药代动力学特性以及在高血压急症和紧急情况管理中的静脉临床应用潜力综述。

Drugs. 1997 Oct;54(4):634-50. doi: 10.2165/00003495-199754040-00008.